ENG

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals

Deal

Bird & Bird advised Bpifrance’s Large Venture on Series A financing round of Bioptimus, a specialist in AI applied to innovation in biomedicine

Jan 22 2025

Read More

Deal

Bird & Bird advises A.T. Kearney on the acquisition of Project Partners Management GmbH

Jan 22 2025

Read More

Deal

Bird & Bird advises RIVE on an additional €270 million bank financing

Jan 21 2025

Read More

Deal

Bird & Bird advised Nexstim on cooperation and investment agreements with Brainlab

Jan 20 2025

Read More

Deal

Bird & Bird advises CDP Venture Capital on Series A investment into Naturbeads

Jan 20 2025

Read More

Deal

Bird & Bird advises Endeit Capital on its Series B investment in Nomupay

Jan 17 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare